Skip to main content
Premium Trial:

Request an Annual Quote

GeneProt to Continue Research for Novartis

NEW YORK, Feb. 5 (GenomeWeb News) - GeneProt has renewed its research collaboration with Novartis Pharma, the company said today.


The Geneva, Switzerland-based proteomics company will continue to analyze the protein content of biological samples and "accelerate the delivery of proteins to Novartis for further biological evaluation," according to a company statement.


GeneProt started a four-year research collaboration with Novartis in 2000. Last year, the company licensed a protein to Novartis, after laying off almost half of it staff.


The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.